Recon: Merck enters immunology space with $11B Prometheus takeover; FDA approves Gamida’s cell therapy
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy